0002050194-26-000004.txt : 20260514
0002050194-26-000004.hdr.sgml : 20260514
20260514163723
ACCESSION NUMBER: 0002050194-26-000004
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20260331
FILED AS OF DATE: 20260514
DATE AS OF CHANGE: 20260514
EFFECTIVENESS DATE: 20260514
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spruce Street Capital LP
CENTRAL INDEX KEY: 0002050194
ORGANIZATION NAME:
EIN: 991180831
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-26325
FILM NUMBER: 26979769
BUSINESS ADDRESS:
STREET 1: 777 THIRD AVENUE
STREET 2: SUITE 1704
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: (646) 416-9712
MAIL ADDRESS:
STREET 1: 777 THIRD AVENUE
STREET 2: SUITE 1704
CITY: NEW YORK
STATE: NY
ZIP: 10017
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0002050194
XXXXXXXX
03-31-2026
03-31-2026
Spruce Street Capital LP
777 THIRD AVENUE
SUITE 1704
NEW YORK
NY
10017
13F HOLDINGS REPORT
028-26325
000333213
801-132577
N
Stephen Leslie Cohen
Chief Operating Officer and Chief Compliance Officer
6464169712
Stephen Leslie Cohen
New York
NY
05-14-2026
0
28
415936109
false
INFORMATION TABLE
2
sprucestreetq1202613f.xml
ALECTOR INC
COM
014442107
4517296
2101068
SH
SOLE
2101068
0
0
ALKERMES PLC
SHS
G01767105
11244197
317992
SH
SOLE
317992
0
0
ALUMIS INC
COM
022307102
8648405
392574
SH
SOLE
392574
0
0
ALTO NEUROSCIENCE INC
COM SHS
02157Q109
29116321
1325210
SH
SOLE
1325210
0
0
AN2 THERAPEUTICS INC
COM
037326105
5575870
1661073
SH
SOLE
1661073
0
0
CENTESSA PHARMACEUTICALS
SPONSORED ADS
152309100
19456802
489849
SH
SOLE
489849
0
0
CENTURY THERAPEUTICS
COM
15673T100
9173462
4059054
SH
SOLE
4059054
0
0
CORVUS PHARMACEUTICALS I
COM
221015100
3388089
231585
SH
SOLE
231585
0
0
DIANTHUS THERAPEUTICS IN
COM
252828108
31325154
373274
SH
SOLE
373274
0
0
ENANTA PHARMACEUTICALS I
COM
29251M106
11778713
932598
SH
SOLE
932598
0
0
ENLIVEN THERAPEUTICS INC
COM
29337E102
12897035
329006
SH
SOLE
329006
0
0
ERASCA INC
COM
29479A108
6836746
422543
SH
SOLE
422543
0
0
HELIX ACQUISITION CORP III
USD CL A ORD SHS
G4444S107
5080000
500000
SH
SOLE
500000
0
0
INHIBIKASE THERAPEUTI
COM NEW
45719W205
6017093
3581603
SH
SOLE
3581603
0
0
KALVISTA PHARMACEUTICALS
COM
483497103
18070319
897681
SH
SOLE
897681
0
0
KINIKSA PHARMACEUTICALS I
ORD SHS CL A
G52694109
36645183
761063
SH
SOLE
761063
0
0
LB PHARMACEUTICALS INC
COM SHS
50180M108
33644866
1376159
SH
SOLE
1376159
0
0
LEONABIO INC
COM
04746L203
3844884
393701
SH
SOLE
393701
0
0
LEXEO THERAPEUTICS INC
COM
52886X107
5330124
928593
SH
SOLE
928593
0
0
MAZE THERAPEUTICS INC
COM
578784100
5970000
200000
SH
SOLE
200000
0
0
MINERVA NEUROSCIENC
COM NEW
603380205
9974388
1655500
SH
SOLE
1655500
0
0
PERSPECTIVE THERAPEUTICS
COM NEW
46489V302
10955036
2627107
SH
SOLE
2627107
0
0
RELAY THERAPEUTICS INC
COM
75943R102
29692044
2984125
SH
SOLE
2984125
0
0
RELMADA THERAPEUTICS INC
COM
75955J402
42998208
6262114
SH
SOLE
6262114
0
0
SAB BIOTHERAPEUTICS IN
COM NEW
78397T202
8420263
2198502
SH
SOLE
2198502
0
0
SAVARA INC
COM
805111101
18472136
3383175
SH
SOLE
3383175
0
0
SURROZEN INC COM NEW
COM NEW
86889P208
12585325
432040
SH
SOLE
432040
0
0
VAXCYTE INC
COM
92243G108
14278150
245709
SH
SOLE
245709
0
0